SEC Form 4 · accession 0001209191-15-056043
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald J Hayden Jr.
Director
Period of report
Jun 23, 2015
Accepted (ET)
Jun 24, 2015 · 7:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Jun 23, 2015 | M | 55,000 | $14.0071 | A | 55,000 | D | |
| Common stockF3 | Jun 23, 2015 | S | 55,000 | $14.0071 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $2.81 | Jun 23, 2015 | M | 10,000 | D | May 24, 2011 | Jun 15, 2020 | Common Stock | 10,000 | 0 | D |
| Stock Options (right to buy) | $4.79 | Jun 23, 2015 | M | 15,000 | D | Jun 13, 2013 | Jun 13, 2022 | Common Stock | 15,000 | 0 | D |
| Stock Options (right to buy) | $3.32 | Jun 23, 2015 | M | 15,000 | D | Jun 12, 2014 | Jun 13, 2023 | Common Stock | 15,000 | 0 | D |
| Stock Options (right to buy) | $2.80 | Jun 23, 2015 | M | 15,000 | D | Jun 10, 2015 | Jun 12, 2024 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2015.
- F2This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.84 to $14.17. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.84 to $14.17. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.